Uveitis & Ocular Inflammation and Regenerative Medicine Research

Last medically reviewed: October 7, 2026

⚠ Important — educational information only, not medical advice

EyeCyte provides educational and scientific information and does not provide medical advice, diagnosis, or treatment. Emerging regenerative and biologic technologies discussed on this website may be experimental, investigational, unapproved, or supported only by preclinical evidence. Patients should discuss medical decisions with appropriately licensed healthcare professionals.
Not an FDA-approved treatment unless explicitly stated. Except where a page names an FDA-approved product, the stem-cell, MSC, exosome, extracellular-vesicle, Wharton’s jelly and other biologic approaches described here are not FDA-approved for any eye condition. Research findings — especially laboratory and animal studies — are not proof that anything works or is safe in people.
Research-Use-Only (RUO): Research-Use-Only (RUO) materials referenced on EyeCyte are for laboratory research by qualified professionals only. They are not drugs, biologics or devices approved for human use, are not intended for administration to people, and are not intended to diagnose, treat, cure, mitigate or prevent any disease.
EyeCyte does not sell, offer, recommend or refer for treatment. Be cautious of any clinic offering unapproved stem-cell or biologic injections for the eye; the FDA has warned of serious harm, including blindness.

Full medical disclaimer · RUO policy · Medical review policy

What is uveitis & ocular inflammation?

Uveitis is inflammation inside the eye, affecting the uvea and sometimes the retina. It can be associated with autoimmune disease, infection, or occur without an identified cause, and can threaten vision.

What causes uveitis & ocular inflammation?

Autoimmune and inflammatory diseases, infections, trauma, and unknown (idiopathic) causes.

What structures or cells are affected?

The iris, ciliary body, choroid and, in some forms, the retina.

How is uveitis & ocular inflammation currently treated or managed?

● Established / Approved

Urgent evaluation by an ophthalmologist or uveitis specialist.
Corticosteroids and immunosuppressive or biologic medicines prescribed by specialists, depending on the cause.

Are these approaches FDA approved for uveitis & ocular inflammation?

● Established / Approved Corticosteroids and certain immunomodulatory medicines are established uveitis care.^[1]

No stem cell or exosome product is FDA-approved for uveitis, to our knowledge as of our last review.^[2]

Why are researchers studying regenerative approaches?

MSCs are studied for their immune-modulating signaling, which has led to animal research in models of autoimmune uveitis.

Research is not treatment. The studies summarized below are investigational. They are presented for education only, do not show that any approach is safe or effective in patients, and are not a recommendation. Unless stated as FDA-approved, none of these approaches is approved for this condition. RUO materials are not for human use.